TLE3 expression is associated with favorable outcomes in taxane-treated patients with non-serous ovarian carcinoma: A multi-institution study

Authors :: Rajmohan Murali
Alison Brand
Paul R. Harnett
Anna deFazio
B.Z. Ring
Robert A. Soslow
Goli Samimi
Catherine J. Kennedy
Raghwa Sharma
Source :: Gynecologic Oncology. 149:182
Publication Year :: 2018
Publisher :: Elsevier BV, 2018.

Subjects :: Oncology
medicine.medical_specialty
Serous fluid
Taxane
business.industry
Internal medicine
Ovarian carcinoma
Obstetrics and Gynecology
Medicine
business

Full Text Access

Tools